STOCK TITAN

Psychemedics Corporation - $PMD STOCK NEWS

Welcome to our dedicated page for Psychemedics Corporation news (Ticker: $PMD), a resource for investors and traders seeking the latest updates and insights on Psychemedics Corporation stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Psychemedics Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Psychemedics Corporation's position in the market.

Rhea-AI Summary
Psychemedics Corporation announces that Brian Hullinger will succeed Ray Kubacki as CEO effective August 17, 2023. Hullinger brings 30 years of leadership experience and a proven track record of driving growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.33%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.51%
Tags
dividends earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.64%
Tags
dividends earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.77%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
management
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
dividends
Psychemedics Corporation

Nasdaq:PMD

PMD Rankings

PMD Stock Data

14.98M
4.39M
22.7%
22.34%
0.27%
Dental Laboratories
Manufacturing
Link
United States of America
ACTON

About PMD

psychemedics (nasdaq: pmd) is the world's leading drug testing company using hair for the detection of drugs of abuse. psychemedics has been successfully operating for 30 years and thousands of corporations worldwide currently rely on psychemedics’ patented hair analysis technology for their pre-employment and employee drug screening. psychemedics'​ clients include over 10% of the fortune 500, some of the largest police departments in america, federal reserve banks, and schools. for more information, visit the psychemedics website at www.psychemedics.com.